Clinical utility of denosumab for treatment of bone loss in men and women
Robert A Adler, Ranjodh S GillEndocrinology and Metabolism, McGuire Veterans Affairs Medical Center, Richmond, VA, USAAbstract: While most older patients with osteoporosis are treated with antiresorptive bisphosphonates such as alendronate, risedronate, ibandronate, and zoledronic acid, such drugs h...
Guardado en:
Autores principales: | Adler R, Gill RS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75b6a79ef62d4aab9660aac39a7c9067 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Frequency of osteoporosis in patients with peptic ulcer disease
por: Amber Amin, et al.
Publicado: (2021) -
Osteonecrosis de los maxilares asociada a medicamentos: revisión de la literatura y propuesta para la prevención y manejo
por: Foncea,Camila, et al.
Publicado: (2020) -
Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014) -
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
por: Pan WL, et al.
Publicado: (2017) -
Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014)